Richtmann, S., Wilkens, D., Warth, A., Lasitschka, F., Winter, H., Christopoulos, P., . . . Schneider, M. (2019). FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC. Cancers, 11(5), . https://doi.org/10.3390/cancers11050652
Chicago-Zitierstil (17. Ausg.)Richtmann, Sarah, et al. "FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC." Cancers 11, no. 5 (2019). https://doi.org/10.3390/cancers11050652.
MLA-Zitierstil (9. Ausg.)Richtmann, Sarah, et al. "FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC." Cancers, vol. 11, no. 5, 2019, https://doi.org/10.3390/cancers11050652.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.